Magneto-NIR-II-Programmed Cascade Nanozymes Unlocking Blood-Brain Barrier Translocation and Autophagic Resistance in Glioblastoma.

Ruocan Liu, Yundi Wu, Shuai Zhang, Hongjuan Zhao, Jiping Zheng, Shiyang Shao, Jianqiang Chen, Xilong Wu

Abstract read

In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ruocan LiuState Key Laboratory of Digital Medical Engineering, School of Biomedical Engineering, School of Pharmaceutical Sciences, Hainan University, Haikou, China.

Yundi WuState Key Laboratory of Digital Medical Engineering, School of Biomedical Engineering, School of Pharmaceutical Sciences, Hainan University, Haikou, China.

Shuai ZhangState Key Laboratory of Digital Medical Engineering, School of Biomedical Engineering, School of Pharmaceutical Sciences, Hainan University, Haikou, China.

Hongjuan ZhaoState Key Laboratory of Digital Medical Engineering, School of Biomedical Engineering, School of Pharmaceutical Sciences, Hainan University, Haikou, China.

Jiping ZhengSchool of Life and Health Sciences, Collaborative Innovation Center of Life and Health, Hainan University, Haikou, China.

Shiyang ShaoSchool of Materials Science and Engineering, Hainan University, Haikou, China.

Jianqiang ChenKey Laboratory of Emergency and Trauma of Ministry of Education, Engineering Research Center for Hainan Biological Sample Resources of Major Diseases, The First Affiliated Hospital, Hainan Medical University, Haikou, China.

Xilong WuState Key Laboratory of Digital Medical Engineering, School of Biomedical Engineering, School of Pharmaceutical Sciences, Hainan University, Haikou, China.ORCID https://orcid.org/0000-0002-5689-538X

Funding

Hainan Province Science and Technology Special Fund ZDYF2023SHFZ142Hainan Province Science and Technology Special Fund ZDYF2025SHFZ026Hainan University XTCX2022JKB06Key Laboratory of Emergency and Trauma of Ministry of Education in Hainan Medical University KLET-202606Nanhai Innovation Talent Program (Education Sector) of Hainan Province 2025NHYC403National Natural Science Foundation of China 22065011National Natural Science Foundation of China 52073077

6 · The paper itself

Abstract

Glioblastoma (GBM) remains a highly aggressive central nervous system malignancy, and its treatment is hindered by poor drug accumulation across the blood-brain barrier (BBB) and autophagy-mediated repair. To address these barriers, rare-earth-doped Nd

Indexed as

autophagy suppressionblood–brain barriercascade nanozymesglioblastomamagnetic guidanceNIR‐II photodynamic therapy

Identifiers

PMID42554584

DOI10.1002/advs.76998

PMCPMC13440201

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.